Sign In
Buy SPHRY
$5.70
+0.400 (+7.55%)
At Close: Aug 10, 2026
Starpharma Viraleze: COVID-19 Nasal Spray Development
07:30pm, Friday, 20'th Nov 2020
Viraleze antiviral could be effective against SAS-CoV-2 and RSV. Boston Consulting Group is involved in positioning and marketing this preventative/early stage infection product. Viraleze has a fast-t
